European Medicines Agency: Link Between AstraZeneca COVID Vaccine & Rare Blood Clots – But ‘Benefits Far Outweigh Risks’ 07/04/2021 Elaine Ruth Fletcher Following a second meeting of the EMA’s safety committee in as many weeks, the European Medicines Agency said that there appears to be a link between receipt of the AstraZeneca vaccine and very rare cases of blood clots being seen in some people – mainly younger women – within two weeks of their jab. The […] Continue reading -> Uganda Green Lights Private Imports Of COVID-19 Vaccines – Kenya Nixes Similar Initiative 06/04/2021 Esther Nakkazi In what may be a first for the African continent, the Ugandan government has decided to allow private sector health providers to import and distribute their own COVID-19 vaccines amidst strict regulations – in an effort to expedite the country’s vaccination drive, which is caught in the crosswinds of vaccine supply shortages plaguing the entire […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> Exclusive: Outcry Over Pakistan’s Unprecedented Plan To Sell COVID Vaccines On Private Market – Now On Hold Over Price Dispute 26/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – (EXCLUSIVE) A controversial plan to sell Russia’s Sputnik V COVID-19 vaccine to wealthy citizens in Pakistan has been put on hold following a dispute between the government and the private pharmaceutical company involved over the vaccines’ sale price, Health Policy Watch has learned. Meanwhile, Transparency International – Pakistan appealed to Prime Minister Imran […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts
Uganda Green Lights Private Imports Of COVID-19 Vaccines – Kenya Nixes Similar Initiative 06/04/2021 Esther Nakkazi In what may be a first for the African continent, the Ugandan government has decided to allow private sector health providers to import and distribute their own COVID-19 vaccines amidst strict regulations – in an effort to expedite the country’s vaccination drive, which is caught in the crosswinds of vaccine supply shortages plaguing the entire […] Continue reading -> Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> Exclusive: Outcry Over Pakistan’s Unprecedented Plan To Sell COVID Vaccines On Private Market – Now On Hold Over Price Dispute 26/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – (EXCLUSIVE) A controversial plan to sell Russia’s Sputnik V COVID-19 vaccine to wealthy citizens in Pakistan has been put on hold following a dispute between the government and the private pharmaceutical company involved over the vaccines’ sale price, Health Policy Watch has learned. Meanwhile, Transparency International – Pakistan appealed to Prime Minister Imran […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts
Damage To Millions Of J&J COVID Vaccines At US Production Plant Could Delay Deliveries, While US Heads Into Fourth Wave 02/04/2021 Madeleine Hoecklin A mix-up with vaccine ingredients at a production site in Baltimore, Maryland, which is manufacturing both the Johnson & Johnson and AstraZeneca COVID-19 vaccines, has led to the contamination of 15 million J&J doses, which risks delaying national and global deliveries of the recently-approved vaccine. The pharma company, which is producing the world’s first single […] Continue reading -> Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> Exclusive: Outcry Over Pakistan’s Unprecedented Plan To Sell COVID Vaccines On Private Market – Now On Hold Over Price Dispute 26/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – (EXCLUSIVE) A controversial plan to sell Russia’s Sputnik V COVID-19 vaccine to wealthy citizens in Pakistan has been put on hold following a dispute between the government and the private pharmaceutical company involved over the vaccines’ sale price, Health Policy Watch has learned. Meanwhile, Transparency International – Pakistan appealed to Prime Minister Imran […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts
Views from a vaccine manufacturer: Q&A – Abdul Muktadir, Incepta Pharmaceuticals 01/04/2021 Priti Patnaik The debate around technology transfer is proving to be critical in addressing shortages in the production of vaccines. We wanted to know from developing country manufacturers on the challenges they face in making vaccines for COVID-19. Geneva Health Files brings you an interview with Abdul Muktadir, Chairman and Managing Director of the Dhaka-based company Incepta […] Continue reading -> The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> Exclusive: Outcry Over Pakistan’s Unprecedented Plan To Sell COVID Vaccines On Private Market – Now On Hold Over Price Dispute 26/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – (EXCLUSIVE) A controversial plan to sell Russia’s Sputnik V COVID-19 vaccine to wealthy citizens in Pakistan has been put on hold following a dispute between the government and the private pharmaceutical company involved over the vaccines’ sale price, Health Policy Watch has learned. Meanwhile, Transparency International – Pakistan appealed to Prime Minister Imran […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts
The Clock Is Ticking For Vaccine Equity, But WHO Remains Hopeful 01/04/2021 Svĕt Lustig Vijay The World Health Organization (WHO) is hopeful that all healthcare workers can be vaccinated by mid-April, but the clock is ticking away, leaving rich countries only nine days to donate surplus COVID-19 vaccines to the global COVAX facility – which has run out of doses at a crucial time. So far, the WHO has not […] Continue reading -> France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> Exclusive: Outcry Over Pakistan’s Unprecedented Plan To Sell COVID Vaccines On Private Market – Now On Hold Over Price Dispute 26/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – (EXCLUSIVE) A controversial plan to sell Russia’s Sputnik V COVID-19 vaccine to wealthy citizens in Pakistan has been put on hold following a dispute between the government and the private pharmaceutical company involved over the vaccines’ sale price, Health Policy Watch has learned. Meanwhile, Transparency International – Pakistan appealed to Prime Minister Imran […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts
France Enters Third Lockdown, While Europe’s Vaccine Rollout Is Critiqued As “Unacceptably Slow” 01/04/2021 Madeleine Hoecklin France is going into its third national lockdown since the start of the COVID-19 pandemic, after a deadly third wave hit Europe, causing soaring infection and death rates. With an average of more than 37,000 daily new cases over the past week, tougher restrictions have become inevitable. French President Emmanuel Macron announced the new restrictions […] Continue reading -> Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> Exclusive: Outcry Over Pakistan’s Unprecedented Plan To Sell COVID Vaccines On Private Market – Now On Hold Over Price Dispute 26/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – (EXCLUSIVE) A controversial plan to sell Russia’s Sputnik V COVID-19 vaccine to wealthy citizens in Pakistan has been put on hold following a dispute between the government and the private pharmaceutical company involved over the vaccines’ sale price, Health Policy Watch has learned. Meanwhile, Transparency International – Pakistan appealed to Prime Minister Imran […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts
Nigeria Pivots From AstraZeneca To Johnson & Johnson COVID-19 Vaccine 31/03/2021 Paul Adepoju EXCLUSIVE – IBADAN – The Nigerian government has quietly ditched the AstraZeneca COVID-19 vaccine meant to vaccinate tens of millions of citizens, and will gradually shift to the Johnson & Johnson’s one-shot vaccine, saying it is easier to administer. Documents from the Nigerian Primary Healthcare Development Agency (NPHCDA) obtained by Health Policy Watch show […] Continue reading -> Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> Exclusive: Outcry Over Pakistan’s Unprecedented Plan To Sell COVID Vaccines On Private Market – Now On Hold Over Price Dispute 26/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – (EXCLUSIVE) A controversial plan to sell Russia’s Sputnik V COVID-19 vaccine to wealthy citizens in Pakistan has been put on hold following a dispute between the government and the private pharmaceutical company involved over the vaccines’ sale price, Health Policy Watch has learned. Meanwhile, Transparency International – Pakistan appealed to Prime Minister Imran […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts
Johnson & Johnson Strikes Big Vaccine Deal With African Union – But Deliveries Only Begin In 3rd Quarter 2021 29/03/2021 Kerry Cullinan CAPE TOWN – Johnson & Johnson (J&J) will deliver its COVID-19 vaccine to Africa from October after reaching an agreement with the African Union to supply the continent with up to 400 million doses over the next two years. However, Africa may still be struggling to obtain vaccine supplies for some months following last week’s decision […] Continue reading -> Exclusive: Outcry Over Pakistan’s Unprecedented Plan To Sell COVID Vaccines On Private Market – Now On Hold Over Price Dispute 26/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – (EXCLUSIVE) A controversial plan to sell Russia’s Sputnik V COVID-19 vaccine to wealthy citizens in Pakistan has been put on hold following a dispute between the government and the private pharmaceutical company involved over the vaccines’ sale price, Health Policy Watch has learned. Meanwhile, Transparency International – Pakistan appealed to Prime Minister Imran […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts
Exclusive: Outcry Over Pakistan’s Unprecedented Plan To Sell COVID Vaccines On Private Market – Now On Hold Over Price Dispute 26/03/2021 Rahul Basharat Rajput & Muhammed Nadeem Chaudhry ISLAMABAD – (EXCLUSIVE) A controversial plan to sell Russia’s Sputnik V COVID-19 vaccine to wealthy citizens in Pakistan has been put on hold following a dispute between the government and the private pharmaceutical company involved over the vaccines’ sale price, Health Policy Watch has learned. Meanwhile, Transparency International – Pakistan appealed to Prime Minister Imran […] Continue reading -> EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts
EMA Approves Expanded COVID Vaccine Manufacturing Capacity For Europe; India Interrupts COVAX Vaccine Deliveries To Low Income Countries 26/03/2021 Madeleine Hoecklin & Elaine Ruth Fletcher The European Medicines Agency (EMA) has officially authorized expanded capacity in three new vaccine manufacturing facilities on the continent producing AstraZeneca, Pfizer/BioNTech and Moderna vaccines – a move that the agency says should also help pharma suppliers ramp up their deliveries of now scarce vaccines to European Union bloc countries. At the same time, a […] Continue reading -> Posts navigation Older postsNewer posts